Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX W DEXTROSE 2 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX W DEXTROSE 2 5 LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 3 5 IN PLASTIC CONTAINER.
DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER vs DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Peritoneal dialysis solution; dextrose provides osmotic gradient for ultrafiltration and solute removal; low magnesium and low calcium concentrations maintain electrolyte balance.
Delflex with Dextrose 3.5% is a peritoneal dialysis solution that uses a high concentration of dextrose to create an osmotic gradient, drawing water and solutes from the blood across the peritoneal membrane into the dialysate, thereby removing excess fluid and waste products from the body. Dextrose is metabolized locally and systemically.
Intraperitoneal: 2.5% dextrose solution with low magnesium (0.25 mEq/L) and low calcium (2.5 mEq/L); typical exchange volume 2-2.5 L per exchange, 4-5 exchanges per day for continuous ambulatory peritoneal dialysis.
Intraperitoneal administration: 2000 mL per exchange, typically 4 exchanges per day, with dwell times of 4-6 hours (CAPD) or cycler-adjusted for APD.
None Documented
None Documented
Dextrose: 1.5–2 hours (intracellular metabolism); Magnesium: 27–40 hours; Calcium: 2.5–3 hours (exchangeable pool); Low concentrations do not alter endogenous kinetics.
3-5 hours (prolonged in renal impairment; anuria up to 24-36 hours)
Renal: 100% (unchanged dextrose and electrolytes; magnesium and calcium are partially reabsorbed, but net excretion is via urine). Biliary/fecal: negligible.
Renal: >90% unchanged drug; biliary/fecal: minimal (<5%)
Category C
Category C
Peritoneal dialysis solution
Peritoneal dialysis solution